Profile
Barbara-Jean Anne Bormann-Kennedy is listed as a director of Xeris Biopharma Holdings, Inc. in the SEC filings with the most recent date of 2026-06-05. The available context confirms her role as a board director for Xeris Biopharma Holdings, Inc., but does not provide additional public details about her education, prior positions, or other affiliations.
| Role | Director |
|---|
| Notability | 45/100 |
|---|
Board memberships
- Xeris Biopharma Holdings, Inc.
Awards & honors
- Director of Xeris Biopharma Holdings, Inc. (as of 2026-06-05 per SEC filing)
Frequently Asked Questions
Who is BORMANN-KENNEDY BARBARA-JEAN ANNE?
Barbara-Jean Anne Bormann-Kennedy is listed as a director of Xeris Biopharma Holdings, Inc. in the SEC filings with the most recent date of 2026-06-05. The available context confirms her role as a board director for Xeris Biopharma Holdings, Inc., but does not provide additional public details about her education, prior positions, or other affiliations.…
How many SEC Form 4 filings has BORMANN-KENNEDY BARBARA-JEAN ANNE submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Has BORMANN-KENNEDY BARBARA-JEAN ANNE been buying or selling stock?
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($98K) across all tracked filings.
Where can I see all of BORMANN-KENNEDY BARBARA-JEAN ANNE's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.